Predicting clinical outcomes in peritoneal dialysis patients using small solute modeling

Annals of Clinical and Laboratory Science

Volumn 35, Issue 1, 2005, Pages 46-53

  Westhuyzen, Justin ^a   Mills, Karen ^a   Healy, Helen ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Albumin; C reactive protein; Patient survival; Peritoneal dialysis; Technique failure; Urea kinetics

Indexed keywords

C REACTIVE PROTEIN; SERUM ALBUMIN;

ARTICLE; COHORT ANALYSIS; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; HUMAN; INFLAMMATION; KIDNEY FAILURE; LOGISTIC REGRESSION ANALYSIS; MORBIDITY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; SURVIVAL RATE;

ADULT; C-REACTIVE PROTEIN; CREATININE; HUMANS; PATIENT SELECTION; PERITONEAL DIALYSIS; PHYSICAL EXAMINATION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SERUM ALBUMIN; SURVIVAL ANALYSIS; SURVIVORS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 15444362617     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Teehan BP, Schleifer CR, Brown JM, Sigler MH, Raimondo J. Urea kinetic analysis and clinical outcome on CAPD. A five year longitudinal study. Adv Perit Dial 1990;6:181-185.
2. Blake PG, Sombolos K, Abraham G, Weissgarten J, Pemberton R, Che GL, et al. Lack of correlation between urea kinetic indices and clinical outcomes in CAPD patients. Kidney Int 1991;39:700-706.
3. De Alvaro F, Bajo MA, Alvarez-Ude F, Vigil A, Molina A, Coronel G, et al. Adequacy of peritoneal dialysis: Does Kt/v have the same predictive value as in HD? A multicentre study. Adv Perit Dial 1992;8:93-97.
4. Blake PG, Balaskas E, Blake R, Oreopoulos DG. Urea kinetics has limited relevance in assessing adequacy of dialysis in CAPD. Adv Perit Dial 1992;8:65-70.
5. Brandes JC, Piering WG, Beres JA, Blumenthal SS, Fritsche C. Clinical outcome of continuous ambulatory peritoneal dialysis predicted by urea and creatinine kinetics. J Am Soc Nephrol 1992;2:1430-1435.
6. Goodship THJ, Pabblick-Deetjen J, Ward MK, Wilkinson R. Adequacy of dialysis and nutritional status in CAPD. Nephrol Dial Transplant 1993;8:1366-1373.
7. Churchill DN. Adequacy of peritoneal dialysis: How much dialysis do we need? Kidney Int 1994;46:S2-6.
8. Blake PG. Is quantification of dialysis by urea kinetics important in continuous ambulatory peritoneal dialysis? Perit Dial Int 1992;13:S212-214.
9. Twardowski ZJ, Nolph KD, Khanna R, Prowant BE, Ryan LP, Moore HL, et al. Peritoneal equilibration test. Perit Dial Bull 1987;7:138-147.
10. Teehan BP, Schleifer CR, Sigler MH, Gilgore GS. A quantitative approach to the CAPD prescription. Perit Dial Bull 1985 (July-September):152-156.
11. Brandes JC, Piering WF, Beres JA. A method to assess efficacy of CAPD: preliminary results. Adv Perit Dial 1990;6:192-196.
12. Fung L, Pollock CA, Caterson RJ, Mahoney JF, Waugh DA, Macadam C et al. Dialysis adequacy and nutrition determine prognosis in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 1996;7:737-744.
13. The National Cooperative Dialysis Study. Kidney Int 1983;23:S1-122.
14. Arkouche W, Delawari E, My H, Laville M, Abdullah E, Traeger J. Quantification of adequacy of peritoneal dialysis. Perit Dial Int 1993;13:S215-218.
15. Mooraki A, Kliger AS, Goirbon-Brennan NL, Juergensen P. Brown E, Finkelstein FO. Weekly Kt/v urea and selected outcome criteria in 56 randomly selected CAPD patients. Adv Perit Dial 1993;9:92-96.
16. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized controlled trial. J Am Soc Nephrol 2002;13:1307-1319.
17. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999;55;1899-1911.
18. Stenvinkel P. Inflammatory and atherosclerotic interactions in the depleted uremic patient. Blood Purif 2000;19:53-61.
19. Healy H, Reith D, Morgan C, Clague A, Westhuyzen J. Are metalloproteins and acute phase reactants associated with cardiovascular disease in end-stage renal failure? Ann Clin Lab Sci 2000;30:297-306.
20. Westhuyzen J, Healy H. Review: Biology and relevance of C-reactive protein in cardiovascular and renal disease. Ann Clin Lab Sci 2000;30:133-143.
21. Kaysen, GA. The microinflammatory state in uraemia: causes and potential consequences. J Am Soc Nephrol 2001;12:1549-1557.
22. Stenvinkel, P. Inflammatory and atherosclerotic interactions in the depleted uremic patient. Blood Purif 2001;19:53-61.
23. Burnett JR, Watts GF, Vasikaran SD. C-reactive protein: a new cardiovascular risk factor? Med J Aus 2000;173:117-118.
24. Diaz-Buxo JA, Lowrie EG, Lew NL, Zhang H, Lazarus JM. Quality-of-life evaluation using Short Form 36: comparison in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 2000;35:293-300.
25. Davis SJ, Phillips L, Russell GI. Peritoneal solute transport predicts survival on CAPD independently of residual renal function. Nephrol Dial Transplant 1998;13:962-968.
26. Han DS, Lee SW, Kang SW, Choi KH. Factors affecting low values of serum albumin in CAPD patients. Adv Perit Dial 1996;12:288-292.
27. Yeun JY, Kaysen GA. Acute phase reactants and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients. Am J Kidney Dis 1997;30:923-927.
28. Kaysen GA, Yeun J, Depner T. Albumin synthesis, catabolism and distribution in dialysis patients. Mineral Electrol Metab 1997;23:218-224.
29. Goldwasser P, Mittman N, Antignani A, Burrell D, Michel MA, Collier J, et al. Predictors of mortality in hemodialysis patients. J Am Soc Nephrol 1993;3:1613-1622.
30. Lowrie EG, Lew NL. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990;15:458-482.
31. Avram MM, Fein PA, Bonomini L, Mittman N, Loutoby R, Avram DK, et al. Predictors of survival in continuous ambulatory peritoneal dialysis patients: A five year prospective study. Perit Dial Int 1996;16:S190-194.
32. Diaz-Buxo JA, Lowrie EG, Lew NL, Zhang SM, Zhu X, Lazarus JM. Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance. Am J Kidney Dis 1999;33:523-534.
33. Maiorca R, Brunori G, Zubani R Cancarini GC, Manili L, Camerini C, et al. Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study. Nephrol Dial Transplant 1995;10:2295-2305.
34. Rocco MV, Frankenfield DL, Prowant B, Frederick P, Flanigan MJ; Centers for Medicare & Medicaid Services Peritoneal Dialysis Core Indicators Study Group. Risk factors for early mortality in U.S. peritoneal dialysis patients: impact of residual renal function. Perit Dial Int 2002;22:371-379.
35. Davies SJ, Russell L, Bryan J, Phillips L, Russell GI. Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: their interrelationship and prediction of survival. Am J Kidney Dis 1995;26:353-361.
36. Jager KJ, Merkus MP, Dekker FW, Boeschoten EW, Tijssen JGP, Stevens P, et al, for the NECOSAD Study Group. Mortality and technique failure in patients starting chronic peritoneal dialysis: Results of the Netherlands Cooperative Study on the Adequacy of Dialysis. Kidney Int 1999;55:1476-1485.